Evidence map›Paper›PMID 31187606›Full record

ArticleAging cell2019

Renormalized basal metabolic rate describes the human aging process and longevity.

Yasuhiro Kitazoe, Hirohisa Kishino, Kumpei Tanisawa, Keiko Udaka, Masashi Tanaka

Abstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Skin Aging and the Upcoming Role of Ferroptosis in Geroscience.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Energy Metabolism and Aging.The world journal of men's health · 2021
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yasuhiro KitazoeCenter of Medical Information Science, Kochi Medical School, Nankoku, Japan.ORCID 0000-0002-4505-1886
Hirohisa KishinoGraduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan.
Kumpei TanisawaDepartment of Physical Activity Research, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.
Keiko UdakaDepartment of Immunology, Kochi Medical School, Nankoku, Japan.
Masashi TanakaDepartment for Health and Longevity Research, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.

Funding

Japan Agency for Medical Research and Development 15ek0109088h0001Japan Agency for Medical Research and Development 15ek0109088s0401Japan Society for the Promotion of Science 16H02788Ministry of Education, Culture, Sports, Science and Technology 16H02788Ministry of Education, Culture, Sports, Science and Technology A-16H01872Ministry of Education, Culture, Sports, Science and Technology A-22240072Ministry of Education, Culture, Sports, Science and Technology A-25242062Ministry of Education, Culture, Sports, Science and Technology B-21390459Ministry of Education, Culture, Sports, Science and Technology C-21590411Ministry of Education, Culture, Sports, Science and Technology C-26670481Ministry of Education, Culture, Sports, Science and Technology CER-24650414
6 · The paper itself

Abstract

The question of why we age and finally die has been a central subject in the life, medical, and health sciences. Many aging theories have proposed biomarkers that are related to aging. However, they do not have sufficient power to predict the aging process and longevity. We here propose a new biomarker of human aging based on the mass-specific basal metabolic rate (msBMR). It is well known by the Harris-Benedict equation that the msBMR declines with age but varies among individual persons. We tried to renormalize the msBMR by primarily incorporating the body mass index into this equation. The renormalized msBMR (RmsBMR) which was derived in one cohort of American men (n = 25,425) was identified as one of the best biomarkers of aging, because it could well reproduce the observed respective American, Italian, and Japanese data on the mortality rate and survival curve. A recently observed plateau of the mortality rate in centenarians corresponded to the lowest value (threshold) of the RmsBMR, which stands for the final stage of human life. A universal decline of the RmsBMR with age was associated with the mitochondrial number decay, which was caused by a slight fluctuation of the dynamic fusion/fission system. This decay form was observed by the measurement in mice. Finally, the present approach explained the reason why the BMR in mammals is regulated by the empirical algometric scaling law.

Indexed as

Basal MetabolismBody Mass IndexAdolescentAdultAgingAnimalsBiomarkersBody HeightBody WeightHumansLongevityMaleMiceMiddle AgedMitochondriaMortalityBiomarkersallometric scaling lawhuman aging biomarkermitochondrial numbermortality raterenormalization of basal metabolic ratesurvival curve

Identifiers

PMID31187606
PMCPMC6612648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.